Monistat 3 and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is found among people who take Monistat 3, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Monistat 3 and have Dizziness. It is created by eHealthMe based on reports of 2,399 people who have side effects when taking Monistat 3 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 20, 2022

2,399 people reported to have side effects when taking Monistat 3.
Among them, 6 people (0.25%) have Dizziness.


What is Monistat 3?

Monistat 3 has active ingredients of miconazole nitrate. It is often used in vaginal yeast infection. eHealthMe is studying from 2,422 Monistat 3 users for its effectiveness, alternative drugs and more.

What is Dizziness?

Dizziness is found to be associated with 4,534 drugs and 5,293 conditions by eHealthMe.

Number of Monistat 3 and Dizziness reports submitted per year:

Could Monistat 3 cause Dizziness?

Time on Monistat 3 when people have Dizziness *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Dizziness when taking Monistat 3 *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Dizziness when taking Monistat 3 *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 50 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Monistat 3 *:

  1. Augmentin '125': 1 person, 16.67%

Common side effects people have besides Dizziness *:

  1. Hypersensitivity: 2 people, 33.33%
  2. Vulvovaginal Burning Sensation: 2 people, 33.33%
  3. Vulvovaginal Swelling: 1 person, 16.67%
  4. Itching: 1 person, 16.67%
  5. Crying: 1 person, 16.67%
  6. Dehydration (dryness resulting from the removal of water): 1 person, 16.67%
  7. Fever: 1 person, 16.67%
  8. Headache (pain in head): 1 person, 16.67%
  9. Hypotension (abnormally low blood pressure): 1 person, 16.67%
  10. Malaise (a feeling of general discomfort or uneasiness): 1 person, 16.67%

Common conditions people have *:

  1. Fungal Infection: 3 people, 50.00%
  2. Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Monistat 3 and have Dizziness?

Check whether Dizziness is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Monistat 3:

Dizziness treatments and more:

COVID vaccines that are related to Dizziness:

How severe was Dizziness and when was it recovered:

Expand to all the drugs that have ingredients of miconazole nitrate:

Common drugs associated with Dizziness:

All the drugs that are associated with Dizziness:

Common conditions associated with Dizziness:

All the conditions that are associated with Dizziness:

How the study uses the data?

The study uses data from the FDA. It is based on miconazole nitrate (the active ingredients of Monistat 3) and Monistat 3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: